| The gut microbial profile in patients with primary sclerosing cholangitis is distinct from patients with ulcerative colitis without biliary disease and healthy controls M Kummen, K Holm, JA Anmarkrud, S Nygård, M Vesterhus, ML Høivik, ... Gut 66 (4), 611-619, 2017 | 427 | 2017 |
| Work disability in inflammatory bowel disease patients 10 years after disease onset: results from the IBSEN Study ML Høivik, B Moum, IC Solberg, M Henriksen, M Cvancarova, T Bernklev, ... Gut 62 (3), 368-375, 2013 | 282 | 2013 |
| Prevalence of sclerosing cholangitis detected by magnetic resonance cholangiography in patients with long-term inflammatory bowel disease AK Lunder, JR Hov, A Borthne, J Gleditsch, G Johannesen, K Tveit, ... Gastroenterology 151 (4), 660-669. e4, 2016 | 245 | 2016 |
| Altered gut microbiota profile in common variable immunodeficiency associates with levels of lipopolysaccharide and markers of systemic immune activation SF Jørgensen, M Trøseid, M Kummen, JA Anmarkrud, AE Michelsen, ... Mucosal immunology 9 (6), 1455-1465, 2016 | 163 | 2016 |
| Health-related quality of life in patients with ulcerative colitis after a 10-year disease course: results from the IBSEN study ML Hoivik, B Moum, IC Solberg, M Cvancarova, O Hoie, MH Vatn, ... Inflammatory bowel diseases 18 (8), 1540-1549, 2012 | 140 | 2012 |
| Switching from Remicade® to Remsima® is well tolerated and feasible: a prospective, open-label study LCT Buer, BA Moum, M Cvancarova, DJ Warren, AW Medhus, ML Høivik Journal of Crohn's and Colitis 11 (3), 297-304, 2017 | 116 | 2017 |
| Vitamin D deficiency in inflammatory bowel disease: prevalence and predictors in a Norwegian outpatient population SO Frigstad, M Høivik, J Jahnsen, SR Dahl, M Cvancarova, T Grimstad, ... Scandinavian journal of gastroenterology 52 (1), 100-106, 2017 | 113 | 2017 |
| Altered gut microbial metabolism of essential nutrients in primary sclerosing cholangitis M Kummen, LB Thingholm, MC Rühlemann, K Holm, SH Hansen, ... Gastroenterology 160 (5), 1784-1798. e0, 2021 | 102 | 2021 |
| Health-related quality of life in inflammatory bowel disease in a European-wide population-based cohort 10 years after diagnosis G Huppertz-Hauss, ML Høivik, E Langholz, S Odes, M Småstuen, ... Inflammatory Bowel Diseases 21 (2), 337-344, 2015 | 95 | 2015 |
| The cost of inflammatory bowel disease in high-income settings: a Lancet Gastroenterology & Hepatology Commission J Burisch, M Zhao, S Odes, P De Cruz, S Vermeire, CN Bernstein, ... The Lancet Gastroenterology & Hepatology 8 (5), 458-492, 2023 | 93 | 2023 |
| Risk matrix model for prediction of colectomy in a population-based study of ulcerative colitis patients (the IBSEN study) IC Solberg, ML Høivik, M Cvancarova, B Moum Scandinavian journal of gastroenterology 50 (12), 1456-1462, 2015 | 92 | 2015 |
| Anaemia in inflammatory bowel disease: a population‐based 10‐year follow‐up ML Høivik, W Reinisch, M Cvancarova, B Moum, IBSEN Study Group Alimentary pharmacology & therapeutics 39 (1), 69-76, 2014 | 90 | 2014 |
| Fatigue in a population-based cohort of patients with inflammatory bowel disease 20 years after diagnosis: The IBSEN study G Huppertz-Hauss, ML Høivik, LP Jelsness-Jørgensen, R Opheim, ... Scandinavian Journal of Gastroenterology 52 (3), 351-358, 2017 | 83 | 2017 |
| Patients with Crohn's disease experience reduced general health and vitality in the chronic stage: ten-year results from the IBSEN study ML Høivik, T Bernklev, IC Solberg, M Cvancarova, I Lygren, J Jahnsen, ... Journal of Crohn's and Colitis 6 (4), 441-453, 2012 | 82 | 2012 |
| Ankylosing spondylitis and axial spondyloarthritis in patients with long-term inflammatory bowel disease: results from 20 years of follow-up in the IBSEN study AM Ossum, Ø Palm, AK Lunder, M Cvancarova, H Banitalebi, A Negård, ... Journal of Crohn's and Colitis 12 (1), 96-104, 2018 | 77 | 2018 |
| Malignancies in patients with inflammatory bowel disease: results from 20 years of follow-up in the IBSEN study Ø Hovde, ML Høivik, M Henriksen, IC Solberg, MC Småstuen, BA Moum Journal of Crohn's and Colitis 11 (5), 571-577, 2017 | 70 | 2017 |
| Complementary and alternative medicine in patients with inflammatory bowel disease: the results of a population-based inception cohort study (IBSEN) R Opheim, ML Hoivik, IC Solberg, B Moum, IBSEN Study Group Journal of Crohn's and Colitis 6 (3), 345-353, 2012 | 69 | 2012 |
| Use of complementary and alternative medicine in patients with inflammatory bowel disease: results of a cross-sectional study in Norway R Opheim, T Bernklev, MS Fagermoen, M Cvancarova, B Moum Scandinavian journal of gastroenterology 47 (12), 1436-1447, 2012 | 68 | 2012 |
| Irritable bowel-like symptoms in ulcerative colitis are as common in patients in deep remission as in inflammation: results from a population-based study [the IBSEN study] M Henriksen, ML Høivik, LP Jelsness-Jørgensen, B Moum, ... Journal of Crohn's and Colitis 12 (4), 389-393, 2018 | 67 | 2018 |
| Combining anti-TNF-α and vedolizumab in the treatment of inflammatory bowel disease: a case series LCT Buer, ML Høivik, DJ Warren, AW Medhus, BA Moum Inflammatory Bowel Diseases 24 (5), 997-1004, 2018 | 64 | 2018 |
